Albertsons Companies (ACI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Jun, 2026Executive summary
Annual meeting scheduled for August 6, 2026, will be held virtually, allowing all stockholders to participate and vote online or by phone/mail.
CEO reflects on a year of strategic progress, emphasizing productivity, digital transformation, and customer-centric initiatives, with a focus on long-term growth and becoming the most loved grocer.
Fiscal 2025 saw increased loyalty membership, digital sales growth, and significant community contributions, including $497 million in food and financial support.
Forward-looking statements highlight continued investment in technology, sustainability, and personalized customer experiences.
Voting matters and shareholder proposals
Stockholders will vote on: election of 10 directors, ratification of Deloitte & Touche as auditor, advisory say-on-pay vote, two management proposals to amend the Certificate of Incorporation, and one stockholder proposal regarding a human rights report.
Board recommends voting FOR all management proposals and AGAINST the stockholder proposal on human rights policy reporting.
Board of directors and corporate governance
Board will be reduced to 10 members, with 70% independent directors and 30% female representation.
Board committees include Audit, Compensation, Governance, Technology, and Finance, each with defined oversight roles.
Cerberus Capital Management retains director nomination rights based on ownership percentage.
Board leadership is separated, with an independent Chair and CEO.
Annual board and committee evaluations, stock ownership guidelines, and no term limits for directors.
Latest events from Albertsons Companies
- Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 202614 Apr 2026 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202510 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20269 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20267 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20267 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202519 Dec 2025 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and pay, with focus on merger, governance, and ESG.ACI
Proxy Filing1 Dec 2025 - Annual proxy statement outlines voting items and confirms standard shareholder meeting.ACI
Proxy Filing1 Dec 2025